Global Osteoarthritis Gene Therapy Market Research Report 2025(Status and Outlook)

September 2025 | 144 pages | ID: GF0B379093E4EN
Bosson Research

Abstracts

Osteoarthritis gene therapy represents a novel therapeutic approach that involves the delivery of genetic material into joint tissues to modify biological processes underlying the disease, primarily aiming to promote cartilage repair, reduce inflammation, and slow or halt disease progression by targeting pathways such as those involving anabolic factors (e.g., TGF-?, IGF-1), anti-inflammatory cytokines (e.g., IL-1Ra), or inhibitors of catabolic enzymes (e.g., MMPs), with delivery mechanisms often utilizing viral vectors like adeno-associated virus (AAV) or non-viral methods to achieve sustained, localized expression of therapeutic genes. Current market analysis indicates that this segment is in an early but rapidly evolving stage, driven by high unmet medical needs in a large patient population globally, increasing understanding of OA pathophysiology at the molecular level, and growing investment in regenerative medicine; key players include biotech firms and academic institutions advancing candidates through preclinical and early clinical trials, though regulatory pathways, safety concerns related to vector immunogenicity, and challenges in achieving durable efficacy remain significant hurdles to widespread commercialization. The market potential is substantial given the limitations of current symptomatic treatments (e.g., NSAIDs, corticosteroids, joint replacement surgery) and the progressive nature of OA, with optimistic projections contingent on successful clinical outcomes, favorable reimbursement policies, and the development of efficient, targeted delivery systems that minimize off-target effects.

The global Osteoarthritis Gene Therapy market size was estimated at USD 520.75 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 5.20% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Osteoarthritis Gene Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Osteoarthritis Gene Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Osteoarthritis Gene Therapy market.

Global Osteoarthritis Gene Therapy Market: Market Segmentation Analysis


This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

Flexion
GeneQuine
Novartis
Smith & Nephew
Genascence
Kolon TissueGene
Sanofi
Paraxel
Medipost
Mundipharma

Market Segmentation (by Type)

Synovium Injection
Cartilage Injection

Market Segmentation (by Application)

Hospitals and clinics
Orthopedic Centers
Assisted living Facilities
Nursing Homes
Ambulatory Surgical Centers
Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Osteoarthritis Gene Therapy Market
Overview of the regional outlook of the Osteoarthritis Gene Therapy Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Osteoarthritis Gene Therapy Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Osteoarthritis Gene Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Osteoarthritis Gene Therapy
1.2 Key Market Segments
  1.2.1 Osteoarthritis Gene Therapy Segment by Type
  1.2.2 Osteoarthritis Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 OSTEOARTHRITIS GENE THERAPY MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Osteoarthritis Gene Therapy Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Osteoarthritis Gene Therapy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 OSTEOARTHRITIS GENE THERAPY MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Osteoarthritis Gene Therapy Product Life Cycle
3.3 Global Osteoarthritis Gene Therapy Sales by Manufacturers (2020-2025)
3.4 Global Osteoarthritis Gene Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Osteoarthritis Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Osteoarthritis Gene Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Osteoarthritis Gene Therapy Market Competitive Situation and Trends
  3.8.1 Osteoarthritis Gene Therapy Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Osteoarthritis Gene Therapy Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 OSTEOARTHRITIS GENE THERAPY INDUSTRY CHAIN ANALYSIS

4.1 Osteoarthritis Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF OSTEOARTHRITIS GENE THERAPY MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Osteoarthritis Gene Therapy Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy ? April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Osteoarthritis Gene Therapy Market
5.7 ESG Ratings of Leading Companies

6 OSTEOARTHRITIS GENE THERAPY MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Osteoarthritis Gene Therapy Sales Market Share by Type (2020-2025)
6.3 Global Osteoarthritis Gene Therapy Market Size Market Share by Type (2020-2025)
6.4 Global Osteoarthritis Gene Therapy Price by Type (2020-2025)

7 OSTEOARTHRITIS GENE THERAPY MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Osteoarthritis Gene Therapy Market Sales by Application (2020-2025)
7.3 Global Osteoarthritis Gene Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Osteoarthritis Gene Therapy Sales Growth Rate by Application (2020-2025)

8 OSTEOARTHRITIS GENE THERAPY MARKET SALES BY REGION

8.1 Global Osteoarthritis Gene Therapy Sales by Region
  8.1.1 Global Osteoarthritis Gene Therapy Sales by Region
  8.1.2 Global Osteoarthritis Gene Therapy Sales Market Share by Region
8.2 Global Osteoarthritis Gene Therapy Market Size by Region
  8.2.1 Global Osteoarthritis Gene Therapy Market Size by Region
  8.2.2 Global Osteoarthritis Gene Therapy Market Size Market Share by Region
8.3 North America
  8.3.1 North America Osteoarthritis Gene Therapy Sales by Country
  8.3.2 North America Osteoarthritis Gene Therapy Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Osteoarthritis Gene Therapy Sales by Country
  8.4.2 Europe Osteoarthritis Gene Therapy Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Osteoarthritis Gene Therapy Sales by Region
  8.5.2 Asia Pacific Osteoarthritis Gene Therapy Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Osteoarthritis Gene Therapy Sales by Country
  8.6.2 South America Osteoarthritis Gene Therapy Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Osteoarthritis Gene Therapy Sales by Region
  8.7.2 Middle East and Africa Osteoarthritis Gene Therapy Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 OSTEOARTHRITIS GENE THERAPY MARKET PRODUCTION BY REGION

9.1 Global Production of Osteoarthritis Gene Therapy by Region(2020-2025)
9.2 Global Osteoarthritis Gene Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Osteoarthritis Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Osteoarthritis Gene Therapy Production
  9.4.1 North America Osteoarthritis Gene Therapy Production Growth Rate (2020-2025)
  9.4.2 North America Osteoarthritis Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Osteoarthritis Gene Therapy Production
  9.5.1 Europe Osteoarthritis Gene Therapy Production Growth Rate (2020-2025)
  9.5.2 Europe Osteoarthritis Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Osteoarthritis Gene Therapy Production (2020-2025)
  9.6.1 Japan Osteoarthritis Gene Therapy Production Growth Rate (2020-2025)
  9.6.2 Japan Osteoarthritis Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Osteoarthritis Gene Therapy Production (2020-2025)
  9.7.1 China Osteoarthritis Gene Therapy Production Growth Rate (2020-2025)
  9.7.2 China Osteoarthritis Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Flexion
  10.1.1 Flexion Basic Information
  10.1.2 Flexion Osteoarthritis Gene Therapy Product Overview
  10.1.3 Flexion Osteoarthritis Gene Therapy Product Market Performance
  10.1.4 Flexion Business Overview
  10.1.5 Flexion SWOT Analysis
  10.1.6 Flexion Recent Developments
10.2 GeneQuine
  10.2.1 GeneQuine Basic Information
  10.2.2 GeneQuine Osteoarthritis Gene Therapy Product Overview
  10.2.3 GeneQuine Osteoarthritis Gene Therapy Product Market Performance
  10.2.4 GeneQuine Business Overview
  10.2.5 GeneQuine SWOT Analysis
  10.2.6 GeneQuine Recent Developments
10.3 Novartis
  10.3.1 Novartis Basic Information
  10.3.2 Novartis Osteoarthritis Gene Therapy Product Overview
  10.3.3 Novartis Osteoarthritis Gene Therapy Product Market Performance
  10.3.4 Novartis Business Overview
  10.3.5 Novartis SWOT Analysis
  10.3.6 Novartis Recent Developments
10.4 Smith and Nephew
  10.4.1 Smith and Nephew Basic Information
  10.4.2 Smith and Nephew Osteoarthritis Gene Therapy Product Overview
  10.4.3 Smith and Nephew Osteoarthritis Gene Therapy Product Market Performance
  10.4.4 Smith and Nephew Business Overview
  10.4.5 Smith and Nephew Recent Developments
10.5 Genascence
  10.5.1 Genascence Basic Information
  10.5.2 Genascence Osteoarthritis Gene Therapy Product Overview
  10.5.3 Genascence Osteoarthritis Gene Therapy Product Market Performance
  10.5.4 Genascence Business Overview
  10.5.5 Genascence Recent Developments
10.6 Kolon TissueGene
  10.6.1 Kolon TissueGene Basic Information
  10.6.2 Kolon TissueGene Osteoarthritis Gene Therapy Product Overview
  10.6.3 Kolon TissueGene Osteoarthritis Gene Therapy Product Market Performance
  10.6.4 Kolon TissueGene Business Overview
  10.6.5 Kolon TissueGene Recent Developments
10.7 Sanofi
  10.7.1 Sanofi Basic Information
  10.7.2 Sanofi Osteoarthritis Gene Therapy Product Overview
  10.7.3 Sanofi Osteoarthritis Gene Therapy Product Market Performance
  10.7.4 Sanofi Business Overview
  10.7.5 Sanofi Recent Developments
10.8 Paraxel
  10.8.1 Paraxel Basic Information
  10.8.2 Paraxel Osteoarthritis Gene Therapy Product Overview
  10.8.3 Paraxel Osteoarthritis Gene Therapy Product Market Performance
  10.8.4 Paraxel Business Overview
  10.8.5 Paraxel Recent Developments
10.9 Medipost
  10.9.1 Medipost Basic Information
  10.9.2 Medipost Osteoarthritis Gene Therapy Product Overview
  10.9.3 Medipost Osteoarthritis Gene Therapy Product Market Performance
  10.9.4 Medipost Business Overview
  10.9.5 Medipost Recent Developments
10.10 Mundipharma
  10.10.1 Mundipharma Basic Information
  10.10.2 Mundipharma Osteoarthritis Gene Therapy Product Overview
  10.10.3 Mundipharma Osteoarthritis Gene Therapy Product Market Performance
  10.10.4 Mundipharma Business Overview
  10.10.5 Mundipharma Recent Developments

11 OSTEOARTHRITIS GENE THERAPY MARKET FORECAST BY REGION

11.1 Global Osteoarthritis Gene Therapy Market Size Forecast
11.2 Global Osteoarthritis Gene Therapy Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Osteoarthritis Gene Therapy Market Size Forecast by Country
  11.2.3 Asia Pacific Osteoarthritis Gene Therapy Market Size Forecast by Region
  11.2.4 South America Osteoarthritis Gene Therapy Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Osteoarthritis Gene Therapy by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

12.1 Global Osteoarthritis Gene Therapy Market Forecast by Type (2026-2033)
  12.1.1 Global Forecasted Sales of Osteoarthritis Gene Therapy by Type (2026-2033)
  12.1.2 Global Osteoarthritis Gene Therapy Market Size Forecast by Type (2026-2033)
  12.1.3 Global Forecasted Price of Osteoarthritis Gene Therapy by Type (2026-2033)
12.2 Global Osteoarthritis Gene Therapy Market Forecast by Application (2026-2033)
  12.2.1 Global Osteoarthritis Gene Therapy Sales (K Units) Forecast by Application
  12.2.2 Global Osteoarthritis Gene Therapy Market Size (M USD) Forecast by Application (2026-2033)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Osteoarthritis Gene Therapy Market Size Comparison by Region (M USD)
Table 5. Global Osteoarthritis Gene Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Osteoarthritis Gene Therapy Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Osteoarthritis Gene Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Osteoarthritis Gene Therapy Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Gene Therapy as of 2024)
Table 10. Global Market Osteoarthritis Gene Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Osteoarthritis Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Osteoarthritis Gene Therapy Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Osteoarthritis Gene Therapy Sales by Type (K Units)
Table 26. Global Osteoarthritis Gene Therapy Market Size by Type (M USD)
Table 27. Global Osteoarthritis Gene Therapy Sales (K Units) by Type (2020-2025)
Table 28. Global Osteoarthritis Gene Therapy Sales Market Share by Type (2020-2025)
Table 29. Global Osteoarthritis Gene Therapy Market Size (M USD) by Type (2020-2025)
Table 30. Global Osteoarthritis Gene Therapy Market Size Share by Type (2020-2025)
Table 31. Global Osteoarthritis Gene Therapy Price (USD/Unit) by Type (2020-2025)
Table 32. Global Osteoarthritis Gene Therapy Sales (K Units) by Application
Table 33. Global Osteoarthritis Gene Therapy Market Size by Application
Table 34. Global Osteoarthritis Gene Therapy Sales by Application (2020-2025) & (K Units)
Table 35. Global Osteoarthritis Gene Therapy Sales Market Share by Application (2020-2025)
Table 36. Global Osteoarthritis Gene Therapy Market Size by Application (2020-2025) & (M USD)
Table 37. Global Osteoarthritis Gene Therapy Market Share by Application (2020-2025)
Table 38. Global Osteoarthritis Gene Therapy Sales Growth Rate by Application (2020-2025)
Table 39. Global Osteoarthritis Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 40. Global Osteoarthritis Gene Therapy Sales Market Share by Region (2020-2025)
Table 41. Global Osteoarthritis Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 42. Global Osteoarthritis Gene Therapy Market Size Market Share by Region (2020-2025)
Table 43. North America Osteoarthritis Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 44. North America Osteoarthritis Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Osteoarthritis Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 46. Europe Osteoarthritis Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Osteoarthritis Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Osteoarthritis Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 49. South America Osteoarthritis Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 50. South America Osteoarthritis Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Osteoarthritis Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Osteoarthritis Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 53. Global Osteoarthritis Gene Therapy Production (K Units) by Region(2020-2025)
Table 54. Global Osteoarthritis Gene Therapy Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Osteoarthritis Gene Therapy Revenue Market Share by Region (2020-2025)
Table 56. Global Osteoarthritis Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Osteoarthritis Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Osteoarthritis Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Osteoarthritis Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Osteoarthritis Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Flexion Basic Information
Table 62. Flexion Osteoarthritis Gene Therapy Product Overview
Table 63. Flexion Osteoarthritis Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Flexion Business Overview
Table 65. Flexion SWOT Analysis
Table 66. Flexion Recent Developments
Table 67. GeneQuine Basic Information
Table 68. GeneQuine Osteoarthritis Gene Therapy Product Overview
Table 69. GeneQuine Osteoarthritis Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. GeneQuine Business Overview
Table 71. GeneQuine SWOT Analysis
Table 72. GeneQuine Recent Developments
Table 73. Novartis Basic Information
Table 74. Novartis Osteoarthritis Gene Therapy Product Overview
Table 75. Novartis Osteoarthritis Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Novartis Business Overview
Table 77. Novartis SWOT Analysis
Table 78. Novartis Recent Developments
Table 79. Smith and Nephew Basic Information
Table 80. Smith and Nephew Osteoarthritis Gene Therapy Product Overview
Table 81. Smith and Nephew Osteoarthritis Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Smith and Nephew Business Overview
Table 83. Smith and Nephew Recent Developments
Table 84. Genascence Basic Information
Table 85. Genascence Osteoarthritis Gene Therapy Product Overview
Table 86. Genascence Osteoarthritis Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Genascence Business Overview
Table 88. Genascence Recent Developments
Table 89. Kolon TissueGene Basic Information
Table 90. Kolon TissueGene Osteoarthritis Gene Therapy Product Overview
Table 91. Kolon TissueGene Osteoarthritis Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Kolon TissueGene Business Overview
Table 93. Kolon TissueGene Recent Developments
Table 94. Sanofi Basic Information
Table 95. Sanofi Osteoarthritis Gene Therapy Product Overview
Table 96. Sanofi Osteoarthritis Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Sanofi Business Overview
Table 98. Sanofi Recent Developments
Table 99. Paraxel Basic Information
Table 100. Paraxel Osteoarthritis Gene Therapy Product Overview
Table 101. Paraxel Osteoarthritis Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Paraxel Business Overview
Table 103. Paraxel Recent Developments
Table 104. Medipost Basic Information
Table 105. Medipost Osteoarthritis Gene Therapy Product Overview
Table 106. Medipost Osteoarthritis Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Medipost Business Overview
Table 108. Medipost Recent Developments
Table 109. Mundipharma Basic Information
Table 110. Mundipharma Osteoarthritis Gene Therapy Product Overview
Table 111. Mundipharma Osteoarthritis Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Mundipharma Business Overview
Table 113. Mundipharma Recent Developments
Table 114. Global Osteoarthritis Gene Therapy Sales Forecast by Region (2026-2033) & (K Units)
Table 115. Global Osteoarthritis Gene Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 116. North America Osteoarthritis Gene Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 117. North America Osteoarthritis Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 118. Europe Osteoarthritis Gene Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 119. Europe Osteoarthritis Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 120. Asia Pacific Osteoarthritis Gene Therapy Sales Forecast by Region (2026-2033) & (K Units)
Table 121. Asia Pacific Osteoarthritis Gene Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 122. South America Osteoarthritis Gene Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 123. South America Osteoarthritis Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Middle East and Africa Osteoarthritis Gene Therapy Sales Forecast by Country (2026-2033) & (Units)
Table 125. Middle East and Africa Osteoarthritis Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 126. Global Osteoarthritis Gene Therapy Sales Forecast by Type (2026-2033) & (K Units)
Table 127. Global Osteoarthritis Gene Therapy Market Size Forecast by Type (2026-2033) & (M USD)
Table 128. Global Osteoarthritis Gene Therapy Price Forecast by Type (2026-2033) & (USD/Unit)
Table 129. Global Osteoarthritis Gene Therapy Sales (K Units) Forecast by Application (2026-2033)
Table 130. Global Osteoarthritis Gene Therapy Market Size Forecast by Application (2026-2033) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Osteoarthritis Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Osteoarthritis Gene Therapy Market Size (M USD), 2024-2033
Figure 5. Global Osteoarthritis Gene Therapy Market Size (M USD) (2020-2033)
Figure 6. Global Osteoarthritis Gene Therapy Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Osteoarthritis Gene Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Osteoarthritis Gene Therapy Product Life Cycle
Figure 13. Osteoarthritis Gene Therapy Sales Share by Manufacturers in 2024
Figure 14. Global Osteoarthritis Gene Therapy Revenue Share by Manufacturers in 2024
Figure 15. Osteoarthritis Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Osteoarthritis Gene Therapy Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Osteoarthritis Gene Therapy Revenue in 2024
Figure 18. Industry Chain Map of Osteoarthritis Gene Therapy
Figure 19. Global Osteoarthritis Gene Therapy Market PEST Analysis
Figure 20. Global Osteoarthritis Gene Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Osteoarthritis Gene Therapy Market Share by Type
Figure 27. Sales Market Share of Osteoarthritis Gene Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Osteoarthritis Gene Therapy by Type in 2024
Figure 29. Market Size Share of Osteoarthritis Gene Therapy by Type (2020-2025)
Figure 30. Market Size Share of Osteoarthritis Gene Therapy by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Osteoarthritis Gene Therapy Market Share by Application
Figure 33. Global Osteoarthritis Gene Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Osteoarthritis Gene Therapy Sales Market Share by Application in 2024
Figure 35. Global Osteoarthritis Gene Therapy Market Share by Application (2020-2025)
Figure 36. Global Osteoarthritis Gene Therapy Market Share by Application in 2024
Figure 37. Global Osteoarthritis Gene Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Osteoarthritis Gene Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Osteoarthritis Gene Therapy Market Size Market Share by Region (2020-2025)
Figure 40. North America Osteoarthritis Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Osteoarthritis Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Osteoarthritis Gene Therapy Sales Market Share by Country in 2024
Figure 43. North America Osteoarthritis Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Osteoarthritis Gene Therapy Market Size Market Share by Country in 2024
Figure 45. U.S. Osteoarthritis Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Osteoarthritis Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Osteoarthritis Gene Therapy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Osteoarthritis Gene Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Osteoarthritis Gene Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Osteoarthritis Gene Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Osteoarthritis Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Osteoarthritis Gene Therapy Sales Market Share by Country in 2024
Figure 53. Europe Osteoarthritis Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Osteoarthritis Gene Therapy Market Size Market Share by Country in 2024
Figure 55. Germany Osteoarthritis Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Osteoarthritis Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Osteoarthritis Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Osteoarthritis Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Osteoarthritis Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Osteoarthritis Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Osteoarthritis Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Osteoarthritis Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Osteoarthritis Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Osteoarthritis Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Osteoarthritis Gene Therapy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Osteoarthritis Gene Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Osteoarthritis Gene Therapy Market Size Market Share by Region in 2024
Figure 68. China Osteoarthritis Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Osteoarthritis Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Osteoarthritis Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Osteoarthritis Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Osteoarthritis Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Osteoarthritis Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Osteoarthritis Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Osteoarthritis Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Osteoarthritis Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Osteoarthritis Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Osteoarthritis Gene Therapy Sales and Growth Rate (K Units)
Figure 79. South America Osteoarthritis Gene Therapy Sales Market Share by Country in 2024
Figure 80. South America Osteoarthritis Gene Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Osteoarthritis Gene Therapy Market Size Market Share by Country in 2024
Figure 82. Brazil Osteoarthritis Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Osteoarthritis Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Osteoarthritis Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Osteoarthritis Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Osteoarthritis Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Osteoarthritis Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Osteoarthritis Gene Therapy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Osteoarthritis Gene Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Osteoarthritis Gene Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Osteoarthritis Gene Therapy Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Osteoarthritis Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Osteoarthritis Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Osteoarthritis Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Osteoarthritis Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Osteoarthritis Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Osteoarthritis Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Osteoarthritis Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Osteoarthritis Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Osteoarthritis Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Osteoarthritis Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Osteoarthritis Gene Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Osteoarthritis Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Osteoarthritis Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Osteoarthritis Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Osteoarthritis Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Osteoarthritis Gene Therapy Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Osteoarthritis Gene Therapy Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Osteoarthritis Gene Therapy Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Osteoarthritis Gene Therapy Market Share Forecast by Type (2026-2033)
Figure 111. Global Osteoarthritis Gene Therapy Sales Forecast by Application (2026-2033)
Figure 112. Global Osteoarthritis Gene Therapy Market Share Forecast by Application (2026-2033)